TRIUMPH-3 (NCT05882045) is a Phase 3, 80-week, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with severe obesity (Class 2 or Class 3), defined as BMI 35 kg/m 2 , and established cardiovascular disease
You'll have monthly check-ins with your provider, plus access to reach out anytime you need support
Therefore, a more effective approach would be to improve the accumulation of fluorescent probes in tumor lesions, enhancing their distribution and retention
G.HjortnessM
So if someone is already noticing slower digestion, nausea, constipation, bloating, or early fullness on a GLP-1 medication, edibles may not feel as predictable as they did before